The Europe Intracranial Aneurysm Market would witness market growth of 8.3% CAGR during the forecast period (2023-2030).
A portion of the skull is removed during craniotomy to gain access to the brain and execute neurosurgical interventions such as aneurysm coiling, clipping, or other intracranial procedures. Craniotomy provides direct access to the aneurysm site and allows neurosurgeons to perform precise surgical maneuvers while minimizing trauma to surrounding brain tissue.
The fundamental motivation behind the market is the pursuit of accuracy, which is propelled by developments in diagnostic imaging technologies that provide unparalleled visibility into the complex cerebral vasculature. Clinicians rely on digital subtraction angiography (DSA), computed tomography angiography (CTA), and magnetic resonance angiography (MRA) as indispensable instruments that enable them to navigate the complex networks of blood vessels and identify the elusive contributing factors responsible for these potential threats.
According to the Government of UK, from 2021 to 2022, 63.8% of adults aged 18 years and over in England were estimated to be overweight or living with obesity. This was an increase from 2020 to 2021 (63.3%). The prevalence of adults who are overweight or living with obesity varies by age in England, with adults aged between 45 and 84 years having a higher estimated prevalence than the England average. Likewise, according to the International Trade Administration (ITA), the medical device sector in France generated €36.7 billion in profit in 2022. It is estimated that medical device exports from France generate a market turnover of €9.4 billion, or 26% of the total market. Over the coming years, the industry is expected to expand by roughly 2% annually. Therefore, rising obesity and the growing medical devices industry in the region propel the market’s growth.
The Germany market dominated the Europe Intracranial Aneurysm Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $142.3 Million by 2030. The UK market is exhibiting a CAGR of 7.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.1% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
A portion of the skull is removed during craniotomy to gain access to the brain and execute neurosurgical interventions such as aneurysm coiling, clipping, or other intracranial procedures. Craniotomy provides direct access to the aneurysm site and allows neurosurgeons to perform precise surgical maneuvers while minimizing trauma to surrounding brain tissue.
The fundamental motivation behind the market is the pursuit of accuracy, which is propelled by developments in diagnostic imaging technologies that provide unparalleled visibility into the complex cerebral vasculature. Clinicians rely on digital subtraction angiography (DSA), computed tomography angiography (CTA), and magnetic resonance angiography (MRA) as indispensable instruments that enable them to navigate the complex networks of blood vessels and identify the elusive contributing factors responsible for these potential threats.
According to the Government of UK, from 2021 to 2022, 63.8% of adults aged 18 years and over in England were estimated to be overweight or living with obesity. This was an increase from 2020 to 2021 (63.3%). The prevalence of adults who are overweight or living with obesity varies by age in England, with adults aged between 45 and 84 years having a higher estimated prevalence than the England average. Likewise, according to the International Trade Administration (ITA), the medical device sector in France generated €36.7 billion in profit in 2022. It is estimated that medical device exports from France generate a market turnover of €9.4 billion, or 26% of the total market. Over the coming years, the industry is expected to expand by roughly 2% annually. Therefore, rising obesity and the growing medical devices industry in the region propel the market’s growth.
The Germany market dominated the Europe Intracranial Aneurysm Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $142.3 Million by 2030. The UK market is exhibiting a CAGR of 7.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.1% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Medtronic PLC
- Stryker Corporation
- MicroPort Scientific Corporation
- Johnson & Johnson
- MicroVention, Inc. (Terumo Corporation)
- B.Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Delta Surgical
- Penumbra, Inc.
Market Report Segmentation
By End-use- Hospitals
- Clinics
- Others
- Endovascular Coiling
- Flow Diverters
- Surgical Clipping
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Intracranial Aneurysm Market by End-use
Chapter 5. Europe Intracranial Aneurysm Market by Type
Chapter 6. Europe Intracranial Aneurysm Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Medtronic PLC
- Stryker Corporation
- MicroPort Scientific Corporation
- Johnson & Johnson
- MicroVention, Inc. (Terumo Corporation)
- B. Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Delta Surgical
- Penumbra, Inc.
Methodology
LOADING...
